M. Fahey

Design and Nuclear Magnetic Resonance (NMR) Structure Determination of the Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) Domain Construct for Binding Site Elucidation in Drug Discovery

D. Jane, J. Hemmings, R. Sessions, 2014, Journal of medicinal chemistry.

TrkAd5: A Novel Therapeutic Agent for Treatment of Inflammatory Pain and Asthma

P. Stroemer, S. Allen, D. Dawbarn, 2006, Journal of Pharmacology and Experimental Therapeutics.

Human ProNGF: biological effects and binding profiles at TrkA, P75NTR and sortilin

C. Catania, Kwangwook Cho, S. Allen, 2008, Journal of neurochemistry.

Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat

S. McMahon, A. Young, P. Yip, 2007, Pain.

NGF receptor TrkAd5: therapeutic agent and drug design target.

R. Sessions, D. Shoemark, L. Brady, 2006, Biochemical Society transactions.

Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF)

Daniel J. Whitcomb, Kwangwook Cho, F. Gunn-Moore, 2016, Pharmacological research.